Effective interventions and treatments for complex diseases have been implemented globally, however, coverage in Africa has been comparatively lower due to lack of capacity, clinical applicability and knowledge on the genetic contribution to disease and treatment. Currently, there is a scarcity of genetic data on African populations, which have enormous genetic diversity. Pharmacogenomics studies have the potential to revolutionise treatment of diseases, therefore, African populations are likely to benefit from these approaches to identify likely responders, reduce adverse side effects and optimise drug dosing.
View Article and Find Full Text PDFBiohydrogen production in an anaerobic fluidized granular bed bioreactor was strongly dependent on temperature and effluent recycle rates. At 45 °C as the effluent recycle rate was increased from 1.3 to 3.
View Article and Find Full Text PDF